Closing the data loop in AI-driven drug discovery; the high cost and long timelines of bringing a new drug to market persist, driven by Eroom’s Law.
Read the original at www.technologyreview.com→Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly...
Original headline: "Closing the data loop in AI-driven drug discovery"
Coverage timeline
- Jul 27, 11:40 UTC MIT Technology Review AI lead source Closing the data loop in AI-driven drug discovery